NovaBridge Biosciences: cashflow_operating
| Value | {"amount": -72697000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "currency": "USD"} |
|---|---|
| Period | 2023-01-01 – 2023-12-31 |
| Status | current |
| Entity | NovaBridge Biosciences |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:00:48.227251+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/5775891d-68e3-4e7e-a23a-c9a733e98425
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000950170-25-050344Retrieved: 2026-08-19T18:00:48.227251+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001778016/cashflow-operating/2023-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/5775891d-68e3-4e7e-a23a-c9a733e98425
History
- supersedes {"amount": -183798000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "currency": "USD"} (evidence 0001104659-24-054452)